Press coverage about Cardinal Health (NYSE:CAH) has been trending somewhat positive on Wednesday, Accern Sentiment reports. The research group rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave media stories about the company an impact score of 46.6518460550512 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:
- Cardinal Health CEO denies wrongdoing on opioids, but holds out possibility of settlement (finance.yahoo.com)
- Cardinal Health fires back at Amazon health-care threat: You can’t beat our prices (marketwatch.com)
- Cardinal Health (CAH) Holder Mcdonald Capital Investors Has Increased Position by $397980 as Share Price … – Hill Country Times (hillcountrytimes.com)
- Hot Stock Analysis: Cardinal Health Inc (NYSE: CAH) – Alpha Beta Stock (alphabetastock.com)
- Are These Just A Random Activities? Cardinal Health, Inc. (CAH), AWeyerhaeuser Company (WY) – Market Movers (financialqz.com)
Several equities research analysts recently issued reports on the stock. Evercore ISI assumed coverage on shares of Cardinal Health in a research report on Thursday, January 4th. They set an “in-line” rating and a $67.00 price objective for the company. ValuEngine cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Deutsche Bank assumed coverage on shares of Cardinal Health in a research report on Monday, December 4th. They set a “hold” rating and a $64.00 price objective for the company. Morgan Stanley cut shares of Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th. Finally, Argus cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $72.99.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.24 earnings per share. equities analysts forecast that Cardinal Health will post 4.95 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date of this dividend is Friday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is currently 53.94%.
ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Cardinal Health (CAH) Stock Price” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2018/01/10/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-cardinal-health-cah-stock-price.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.